ALGENBRAIN

downloadable software using artificial intelligence and CRISPR technology for reverse engineering disease trajectory; downloadable software using artificial intelligence and CRISPR technology for analyzing and identifying dynamic gene expression changes and disease-driving RNA pathways; downloadable software using artificial intelligence and CRISPR technology for predicting gene expression changes during disease progression; downloadable software using artificial intelligence and CRISPR technology for precise gene editing and modulation; downloadable software using artificial intelligence and CRISPR technology for discovering gene targets for further evaluation and development; downloadable software using artificial intelligence and CRISPR technology for use in drug discovery; downloadable software using artificial intelligence and CRISPR technology for use in the identification, isolation, functional analysis, sequencing and mapping of genes; downloadable software using artificial intelligence and CRISPR technology for managing therapeutic discovery activities related to gene networking; downloadable software using artificial intelligence and CRISPR technology for identification, isolation, functional analysis, sequencing and mapping of genes

development of software, artificial intelligence, CRISPR technology, therapeutics, and pharmaceuticals; development of software, artificial intelligence, CRISPR technology, therapeutics, and pharmaceuticals for managing therapeutic discovery activities related to gene networking; research and development in the field of drug discovery; drug discovery services; research and development of therapeutics to treat diseases utilizing a proprietary drug discovery platform; design and development of computer software that utilizes artificial intelligence and CRISPR technology; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for reverse engineering disease trajectory; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, CRISPR technology, machine learning, deep learning, science, chemistry, physics, and biology; computer modeling services; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for analyzing and identifying dynamic gene expression changes and disease-driving RNA pathways; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for predicting gene expression changes during disease progression; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for precise gene editing and modulation; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for discovering gene targets for further evaluation and development; scientific research and product development in the field of genetics and drug discovery; scientific research, namely, identification, isolation, functional analysis, sequencing and mapping of genes; research and development in the field of biotechnology and gene networking technology for use in therapeutic discovery and development; scientific research and technological research in the fields of gene discovery, gene network informatics, and drug discovery; managing therapeutic discovery activities related to gene networking, namely, screening and prioritizing therapeutic agents for further evaluation and development, discovering novel biomarkers, validating biomarker strategies, gathering insights for patient selection and stratification for therapeutic treatment, and generating and storing therapeutic insights about the role a particular gene plays in a given disease and about the mechanism of action and therapeutic index of particular therapeutic agents